Investor Relations Apotheca Biosciences (OTC:CBDC)
Apotheca Biosciences welcomes strategic partners and investors to assist in the discovery and development of its novel platform technologies for unmet market needs. With our state-of-the art lab facilities and world class team, we will be an ideal strategic partner for joint development collaborations and strategic investors exploring innovative approaches that fits with their financial portfolio.
To learn more about Apotheca Biosciences, please visit OTC Markets’ website here.
- 8-K – Current report2 weeks ago
- 8-K – Current report3 weeks ago
- 8-K – Current report4 weeks ago
- 10-Q/A [Amend] – Quarterly report [Sections 13 or 15(d)]4 weeks ago
- 10-Q – Quarterly report [Sections 13 or 15(d)]4 weeks ago
- NT 10-Q – Notification of inability to timely file Form 10-Q or 10-QSB1 month ago
- 8-K – Current report1 month ago
- 8-K – Current report2 months ago
- S-8 POS – Securities to be offered to employees in employee benefit plans, post-effective amendments2 months ago
- 10-K – Annual report [Section 13 and 15(d), not S-K Item 405]2 months ago